Year: 2018

In new research, Hassane Mchaourab and colleagues have uncovered new insights into drug resistance that could lead to the development of new anti-cancer and antibacterial drugs. Read More

Disruption of the integrity of the intestinal lining or epithelium contributes to a “leaky” gut and is a common feature of patients with inflammatory bowel disease. Yash Choksi, Christopher Williams and colleagues found that low levels of a certain protein exacerbated the condition. Read More

Kelsey Hatzell studied the performance of a promising electrolyte for solid-state lithium batteries under real-world conditions. Read More

In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found. Read More

A drug used to treat diabetes, liraglutide, may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. Read More

Principals and districts benefit when principal supervisors move beyond the role of administrator to coach and mentor, according to a new Vanderbilt University report. Read More

One of the first studies to examine the health impacts of legal marriage for LGBT individuals has found gay men were more likely to receive routine medical care following marriage legalization. Read More

In June, Tennessee Governor Bill Haslam discussed leadership with a group of aspiring principals as part of the Governor’s Academy for School Leadership. Read More

Principals and districts benefit when principal supervisors move beyond the role of administrator to coach and mentor, according to a new Vanderbilt University report. Read More

New findings by Jörn-Hendrik Weitkamp and colleagues provide the first account of bacterial signatures in mammalian fetal intestinal tissue. The results suggest that bacterial DNA moves from the mother’s microbiome into the fetal intestine, which may be a critical stimulus for normal mucosal immune development. Read More

Chronic inflammation is a predisposing condition for colorectal cancer, the third leading cause of cancer-related deaths in the United States. Anna Means, Ph.D., and colleagues have now linked inflammation-driven carcinogenesis in the colon to loss of an important signaling protein called SMAD4. Read More

Vanderbilt University and Oak Ridge National Laboratory are combining their expertise in biology, chemistry, physics, mathematics and computation to address pressing problems in biology. Read More

Analysis of data from a clinical trial conducted at Vanderbilt suggests that deep brain stimulation (DBS) administered to patients with very early-stage Parkinson’s disease slowed the progression of rest tremor. The study, published June 29 in Neurology, is significant because it is the first evidence of a treatment that may… Read More

Appello was established with major investment from New York-based Deerfield Management, which specializes in accelerating drug development projects at universities and other nonprofits. Read More

There’s one bond that had scientists stumped: the one between some types of metals and carbon. Professor of Chemistry Timothy Hanusa set out to replicate this unique type of bond using modeling. Read More

Lipid molecules that bind to HDL can modify its function — and blocking that modification can protect HDL and potentially lower the risk of atherosclerosis and heart disease. Read More

Doctors at Vanderbilt University Medical Center are urging caution with consumer fireworks as the Fourth of July approaches. Read More

The new factor, an enzyme involved in host-pathogen interactions, may be a viable target for treating staph infections. Read More

The Vanderbilt Alumni Association Board announces new leadership and the addition of eight new board members. Read More

T. Alp Ikizler, MD, an internationally known expert on the nutritional and metabolic aspects of kidney disease, will succeed Raymond Harris, MD, as director of the Department of Medicine’s Division of Nephrology and Hypertension in the Vanderbilt University School of Medicine effective July 1. Read More